
Generative AI for Novel Therapies | Sean McClain, Absci
Nucleate Podcast
00:00
Introduction
Sean McLean, CEO of Abzai, discusses the company's journey from bio manufacturing enhancements to pioneering AI drug discovery with generative AI models. Learn how Sean's leadership has led to Abzai's remarkable achievements in raising capital, going public, and revolutionizing biologics design.
Transcript
Play full episode